News Releases

News Release

Meridian Bioscience to Present at UBS Global Life Science Conference

September 23, 2005 at 8:54 AM EDT

CINCINNATI--(BUSINESS WIRE)--Sept. 23, 2005--Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that the Company has been invited to present at the UBS Global Life Sciences Conference, Tuesday, September 27, 2005 at 12:00 p.m. ET at the Grand Hyatt New York in New York City. Bill Motto, Chairman and CEO and Jack Kraeutler, President and COO, are scheduled to present. A question and answer session will follow and some of the information provided during the session may not have been previously disclosed. Mr. Motto and Mr. Kraeutler will be available to meet with investors during the Conference.

Meridian invites investors to listen to management's remarks, live over the Internet at 12:00 p.m. ET on September 27, on the Company's website at The archived broadcast will be available at 3:00 p.m. on September 27, 2005 until October 29, 2005.

Meridian is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. Utilizing a variety of methods, these products provide accuracy, simplicity and speed in the early diagnosis and treatment of common medical conditions, such as gastrointestinal, viral, urinary and respiratory infections. All Meridian diagnostic products are used outside of the human body and require little or no special equipment. The Company's products are designed to enhance patient well-being while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal and upper respiratory infections, serology, parasitology and fungal disease diagnosis. In addition, Meridian is a supplier of rare reagents and specialty biologicals along with proteins and other biologicals used by biopharmaceutical companies engaged in research for new drugs and vaccines. The Company markets its products to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices and diagnostics manufacturers in more than 60 countries around the world. The Company's shares are traded through Nasdaq's National Market, symbol VIVO. Meridian's website address is

CONTACT: Meridian Bioscience, Inc.
John A. Kraeutler, 513-271-3700

SOURCE: Meridian Bioscience, Inc.